Sickle cell disease (SCD) is an inherited, lifelong chronic disorder affecting nearly 100,000 Americans and a growing global health problem that will touch nearly 30 percent more people globally in the next three decades. Though new approaches to managing SCD have led to improvements in diagnosis and supportive care, people living with the disease still have severe complications to overcome. Many are unable to access quality care and are limited by a lack of effective treatment options.
In an effort to identify unmet medical needs for people with SCD, the American Society of Hematology (ASH), along with other groups, issued the State of Sickle Cell Disease: 2016 Report, evaluating the disease in four priority areas — access to care, training and professional education, research and clinical trials, and global health. The report shows that significant improvements are needed across all areas and that, though patients are living longer, the system of care needs to change to ensure a better quality of life. To address these challenges, ASH launched the Sickle Cell Disease Coalition along with more than 20 other organizations who are issuing a call to action that will amplify the voice of the SCD community, promote SCD awareness, and transform SCD care both in the United States and around the globe.
To view the multimedia release go to:
http://www.multivu.com/players/English/7903251-american-society-hematology-sickle-cell-coalition/
Team In Training. Light The Night. Man & Woman of the Year. Student Series. Leukemia Cup Regatta. More than 13 million participants in these popular fundraising campaigns last year alone helped The Leukemia & Lymphoma Society (LLS) invest more than $1 billion in research to advance lifesaving treatments and cures for blood cancer patients.
For Blood Cancer Awareness Month this September, LLS is reminding us that despite progress, much work still needs to be done to save more lives. More than 1.2 million people in the U.S. are living with or in remission from a blood cancer. Leukemia causes more deaths than any other cancer among children, adolescents and adults younger than 20 years. Leukemia, lymphoma and myeloma are expected to cause the deaths of an estimated 58,320 people in the U.S. in 2016.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554853-lls-blood-cancer-awareness-month/
For the past six years Brookdale, the nation’s largest senior living provider, has fulfilled its residents’ life-long dreams and Wishes by partnering with Wish of a Lifetime™, an organization dedicated to shifting the way society views and values our oldest generation. During this time, some of the most exciting Wishes have taken place in the skies above. Since the partnership began, more than 70 aerial themed Wishes have been granted to Brookdale residents who had dreams of skydiving, taking helicopter tours, flying fighter jets and more.
“Seeing our residents fulfill their Wish of a Lifetime through these incredible aviation adventures shows how older adults continue to act on their dreams and passions,” says Sara Terry, vice president of resident and family engagement. “We are always thrilled to find opportunities for our residents to enrich their lives and honor their spirit.”
To view the multimedia release go to:
http://www.multivu.com/players/English/77221510-brookdale-senior-wish-of-a-lifetime/
If you think that fall signals the end of heartworm season, think again. The American Heartworm Society (AHS) cautions the pet-owning public that heartworm disease is not solely a summer threat.
To help pet owners spread the word that heartworm is a year-round problem, as well as one of the most common diseases in pets, AHS created a video message that pet owners can forward to their friends. The “Is Your Pet Protected?” video emphasizes that this deadly disease is easy to prevent—but knowledge is needed to help all pet owners understand the importance of year-round protection and the importance of prevention.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52009-american-heartworm-society-urges-year-round-pet-protection
Klişe bir laf ama adamlar uzaya araç gönderirken, İslam dünyasında hâlâ dünya düz mü değil mi diye tartışılması gerçekten trajik. Bu tartışma birçok müslümana bile saçma gelecektir eminim. Ancak konu din olunca ve her şeyin ölçütü kutsal kitaplar olarak görüldüğünde, gerçeklerin orada yazanlara uydurulması bilindik bir durum haline gelmekte. İşte bu sebeple, 1975 yılında Suudi Arabistan'ın en önemli din otoritesi kabul edilen Şeyh Abdul Aziz Bin Baz tarafından Dünya'nın düz olduğu fetvası verilmiş ve buna inanmayanların dinsiz kabul edilerek, cezelandırılması gerektiği bildirilmiştir. Bugün, ülkemizde, hadisleri baz alarak Adem'in dinozorlarla aynı dönemde yaşadığını ve 30 m. uzunlukta olduğunu söyleyen biyoloji profesörlerimiz varken, dünyanın düz olduğunu söyleyen uzmanlar hiçbir müslümanı da şaşırtmamalı. ("Kuran'da Dünya'nın düz olarak geçtiğini söyleyenlere itirazınız var da, evrim yalandır diyenlere niye yok?" diye bir soru yönlendirilebilir kendilerine.)
Şüphesiz buna inananlar sadece müslümanlar değil. 1956 yılında Britanya'da, Flat Earth Society (Düz Dünya Cemiyeti) adıyla, Dünya'nın düz olduğunu savunan ve bugün hala aktif olan bir organizasyon bile kuruldu. Bilim karşıtlığı hiçbir zaman popülaritesini yitirmiyor.
Konuyla ilgili olarak aşağıdaki kaynaklara bakmanızı da tavsiye ederim:
http://www.bilimfelsefedin.org/?p=377
http://suphecimelek.wordpress.com/2010/05/21/gunesin-battigi-yer/
http://www.mucizeyalanlari.com/gunesin-gidis-istikameti/
http://wikiislam.net/wiki/Flat_Earth_and_the_Qur%27an (İngilizce)
http://www.loc.gov/exhibits/world/images/s104.jpg (Zekeriya bin Mahmut el Kazvini'nin 16. yy'da Arapça'dan Türkçe'ye çevrilmiş astronomi kitabı Acaibul Mahlukat'tan alınan bu tasvirde, Dünya bir büyükbaş hayvanın üzerinde duran düz bir disk olarak tasvir ediliyor.)
Society for Science & the Public (Society) today announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is the new title sponsor of the Science Talent Search. Selected through a competitive process that garnered interest from the nation’s leading companies and philanthropists, Regeneron will become only the third sponsor in 75 years of the nation’s oldest and most prestigious high school science competition.
The new sponsorship will be celebrated at a special event today at the American Museum of Natural History, which is known for its extensive science education program. The event will be hosted by astrophysicist Neil deGrasse Tyson, Ph.D., Frederick P. Rose director of the Hayden Planetarium at the American Museum of Natural History, and can be viewed via webcast at 9:00 a.m. EDT at http://edge.media-server.com/m/go/sciencetalentsearch.
Regeneron is committing $100 million to support the Science Talent Search and other Society programs through 2026 and will assume title sponsorship of the competition effectively immediately. As part of its commitment, Regeneron is nearly doubling the overall award distribution to $3.1 million annually, increasing the top award to $250,000, and doubling the awards for the top 300 young scientists and their schools to $2,000 each. During its history, the Science Talent Search has provided more than $25 million in awards to over 8,500 students and schools.
To view the multimedia release go to:
http://www.multivu.com/players/English/7846351-regeneron-science-talent-search/
After only 16 weeks of existence, foetuses hear and respond to music as long as it is emitted from their mother’s vagina. Foetuses respond to this stimulus by opening their mouths and pulling their tongues out as far as possible, making vocalisation movements – prior to the acquisition of language.
This is the main conclusion of the study conducted by the team of Institut Marquès, which boasts the collaboration of Alberto Prats, Professor of Anatomy and Human Embryology of the Faculty of Medicine of the University of Barcelona.
The study, entitled “Foetal facial expression in response to intravaginal music emission”, is published this week in the journal Ultrasound of the British Medical Ultrasound Society (BMUS).
According to Dr. Marisa López-Teijón, the Head of Assisted Reproduction at Institut Marquès and the principal researcher and author of the clinical study: “We have discovered that the formula for foetuses to hear like us is to emit music from the mother’s vagina. They barely hear the sound that reaches them through their mother’s abdomen: the soft tissues of the abdomen and the inside of the mother’s body absorb the soundwaves”.
To view the multimedia release go to:
http://www.multivu.com/players/English/7647351-how-foetuses-hear-musical-stimuli/
The National Inventors Hall of Fame®, in partnership with the United States Patent and Trademark Office (USPTO), will host the Greatest Celebration of American Innovation on May 3-4 in our Nation’s Capital. Events will recognize and celebrate 15 pioneers who have significantly contributed to society through their scientific breakthroughs and patented innovations, culminating in a formal Induction Ceremony on May 4.
This year’s class of Inductees includes innovators such as Iver Anderson (Lead-Free Solder), Marshall Jones (Industrial Lasers), Frances Ligler (Portable Optical Biosensors), and Howard Head (Laminate Ski; Oversized Tennis Racket), just to name a few. To view the full list of 2017 Inductees, visit: http://prn.to/2lgdW84.
To view the multimedia release go to:
https://www.multivu.com/players/English/8040951-national-inventors-hall-of-fame-2017/
Toyota Motor Corporation (Toyota) has launched “Start Your Impossible” – a global corporate initiative that aims to inspire Toyota employees, partners, and customers and connect them with the company’s core beliefs. In an age of accelerating technological and environmental developments, “Start Your Impossible” marks Toyota’s commitment to support the creation of a more inclusive and sustainable society in which everyone can challenge their impossible.
Toyota believes that mobility goes beyond cars; it is about overcoming challenges and making dreams come true. The “Start Your Impossible” initiative reflects these values and highlights the company’s goal to provide freedom of mobility for all. “We want to share this thinking with all stakeholders, including consumers, so that we can approach this challenge together,” said Toyota President, Akio Toyoda.
To view the multimedia release go to:
https://www.multivu.com/players/English/8193651-toyota-global-campaign-for-olympic-paralympic-games/
Takeda today announced the launch of a new expert Report on COPD, introduced at a Takeda organised press conference on the occasion of the 2012 European Respiratory Society (ERS) Annual Congress taking place from 1- 5 September in Vienna, Austria.
The Report, entitled ‘The Shifting Paradigm in Chronic Obstructive Pulmonary Disease (COPD) Management,’ was initiated and developed by Takeda Pharmaceuticals International GmbH and is a compilation of opinion articles from a panel of key international respiratory experts, the European Federation of Allergy and Airways Diseases Patients’ Association (EFA) and COPD patients, reflecting updated guidance and research. The new expert Report was developed in response to a recent shift in emphasis in COPD management which now places future risk at equal importance to treatment of current disability. Treatment objectives are now divided into two groups: reducing symptoms and reducing risk.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56582-expert-report-on-copd-launch
Patients and scientists from across the country are featured in the latest “From Hope to Cures” ad campaign launched today by the Pharmaceutical Research and Manufacturers of America (PhRMA), which represents the country’s leading biopharmaceutical researchers and biotechnology companies.
This continuation of PhRMA’s “From Hope to Cures” campaign, first launched in January 2014, highlights the value biopharmaceutical innovation provides to patients, society and the economy. The latest ad campaign, featuring print, radio and digital advertising, highlights the stories of patients who benefit from the medicines developed by biopharmaceutical companies and the scientists who work every day to develop life-saving treatments and cures.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7350552-phrma-from-hope-to-cures/
Three and a half years after beginning a clinical trial which demonstrated the first successful and sustained use of genetically engineered T cells to fight leukemia, a research team from the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia will today announce the latest results of studies involving both adults and children with advanced blood cancers that have failed to respond to standard therapies. The findings from the first 59 patients who received this investigational, personalized cellular therapy, known as CTL019, will be presented during the American Society of Hematology’s Annual Meeting and Exposition in New Orleans.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64691-penn-medicine-reports-research-leukemia-patients-cellular-therapy-ctl019
